Your browser doesn't support javascript.
loading
Pediatric formulation development - Challenges of today and strategies for tomorrow: Summary report from M-CERSI workshop 2019.
Tan, David Cheng Thiam; Khong, Yuet Mei; Mount, Steven; Galella, Elizabeth; Mitra, Biplob; Charlton, Stuart; Kuhli, Maren; Ternik, Robert; Walsh, Jennifer; Rajapakshe, Asha; Thompson, Karen; Mehrotra, Shailly; Santangelo, Matthew; Liu, Jing; Dixit, Trupti; Schaufelberger, Daniel; Jamzad, Shahla; Klein, Sandra; Hoag, Stephen W; Wang, Jian; Fletcher, Elimika Pfuma; Khurana, Mona; Alexander, John; Radden, Erica; Sood, Ramesh; Selen, Arzu.
Afiliação
  • Tan DCT; AbbVie Inc., North Chicago, IL, United States. Electronic address: cheng.tan@abbvie.com.
  • Khong YM; AbbVie Inc., North Chicago, IL, United States.
  • Mount S; Astra Zeneca, Macclesfield, United Kingdom.
  • Galella E; Bristol-Myers Squibb, New Brunswick, NJ, United States.
  • Mitra B; Bristol-Myers Squibb, Summit, NJ, United States.
  • Charlton S; Bristol-Myers Squibb, Moreton, CH46 1QW, United Kingdom.
  • Kuhli M; Daiichi Sankyo Europe GmbH, 85276 Pfaffenhofen, Germany.
  • Ternik R; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, United States.
  • Walsh J; Jenny Walsh Consulting Ltd, BioCity Nottingham, NG1 1GF, United Kingdom.
  • Rajapakshe A; Merck & Co Inc., West Point, PA, United States.
  • Thompson K; Merck & Co Inc., West Point, PA, United States.
  • Mehrotra S; Otsuka Pharmaceutical Development & Commercialization, Princeton, NJ, United States.
  • Santangelo M; Pfizer Inc., Groton, CT, United States.
  • Liu J; Pfizer Inc., Groton, CT, United States.
  • Dixit T; Pfizer Inc., Lake Forest, IL, United States.
  • Schaufelberger D; Schaufelberger Consulting LLC, NJ, United States.
  • Jamzad S; Sunovion Pharmaceuticals, Marlborough, MA, United States.
  • Klein S; University of Greifswald, Department of Pharmacy, Institute of Biopharmaceutics and Pharmaceutical Technology, Greifswald, Germany.
  • Hoag SW; University of Maryland, School of Pharmacy, Baltimore, MD, United States.
  • Wang J; U.S. Food and Drug Administration (FDA), Silver Spring, MD, United States.
  • Fletcher EP; U.S. Food and Drug Administration (FDA), Silver Spring, MD, United States.
  • Khurana M; U.S. Food and Drug Administration (FDA), Silver Spring, MD, United States.
  • Alexander J; U.S. Food and Drug Administration (FDA), Silver Spring, MD, United States.
  • Radden E; U.S. Food and Drug Administration (FDA), Silver Spring, MD, United States.
  • Sood R; U.S. Food and Drug Administration (FDA), Silver Spring, MD, United States.
  • Selen A; U.S. Food and Drug Administration (FDA), Silver Spring, MD, United States. Electronic address: arzu.Selen@fda.hhs.gov.
Eur J Pharm Biopharm ; 164: 54-65, 2021 Jul.
Article em En | MEDLINE | ID: mdl-33878432
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Comprimidos / Preparações Farmacêuticas / Desenvolvimento de Medicamentos Tipo de estudo: Prognostic_studies Limite: Child / Humans Idioma: En Revista: Eur J Pharm Biopharm Assunto da revista: FARMACIA / FARMACOLOGIA Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Comprimidos / Preparações Farmacêuticas / Desenvolvimento de Medicamentos Tipo de estudo: Prognostic_studies Limite: Child / Humans Idioma: En Revista: Eur J Pharm Biopharm Assunto da revista: FARMACIA / FARMACOLOGIA Ano de publicação: 2021 Tipo de documento: Article